STARTUP PROFILE

Phosphoenix

COUNTRY
Netherlands
FOUNDED
2019
CATEGORY
Brain-Computer Interface
Developing an implantable visual brain prosthesis that electrically stimulates the brain to restore rudimentary vision in blind individuals.
Visit website →
Market Notes · Biweekly

Track this company

Funding, launches and regulatory moves across the neurotech startup map.

Subscribed. Check your inbox to confirm.

•
Neurofounders Insights
$   Funding   -
Series A
MODALITY
Intracortical
FORM FACTOR
Implant
INTERFACE DEPTH
Implantable
INDICATION
Vision
TARGET USER
Patients
REGULATORY STAGE
Investigational
Moving the stimulation target from visual cortex to the LGN directly addresses the narrow visual-field coverage that limited earlier prostheses like Second Sight's Orion. Backing from the Netherlands Institute for Neuroscience and EIC grant funding gives the science real institutional weight, though the new probe generation is still pre-clinical.
•
Mentioned in Market Notes
MOST RECENT COVERAGE
#
10
Neurotech Has Arrived
15 September – 29 September 2026

Phosphoenix raised €1.3M to prepare for the first-in-human study of its visual neuroprosthesis. Its Fountain Probe carries more than 1,000 microelectrodes and directly stimulates the brain's visual pathway, bypassing damage to the eye or optic nerve.

Articles featuring
Phosphoenix
No items found.